← FDA DRUG APPROVALS

FDA NDA · NDA020531

METRONIDAZOLE

Sponsor: GALDERMA LABS LP

APPLICATION
NDA020531
TYPE
NDA
ORIGINAL APPROVAL
1995-09-20
LATEST ACTION
2002-08-30
ROUTE
TOPICAL
DOSAGE FORM
CREAM
MARKETING STATUS
Prescription

Products

METROCREAM · ReferencePrescription
METRONIDAZOLE 0.75% · CREAM · TOPICAL

Approval history

2002-08-30Manufacturing (CMC) · Supplement 1 · standardAP
1995-09-20Type 3 - New Dosage Form · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →